共 23 条
[5]
Cohen S., 2022, Antimicrob Steward Healthc Epidemiol, V2, DOI [10.1017/ash.2022.196, DOI 10.1017/ASH.2022.196]
[6]
Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2022, 328 (20)
:2062-2064